MEDIROM Healthcare Technologies Inc. (MRM)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 5.99 |
| Open | 5.93 |
| Bid | 5.91 x 100 |
| Ask | 6.01 x 100 |
| Day's range | 5.93 - 5.99 |
| 52-week range | 3.50 - 7.40 |
| Volume | |
| Avg. volume | 2,664 |
| Market cap | 29.246M |
| Beta (5Y monthly) | 0.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Announcement Execution of Memorandum of Understanding for Share Acquisition (Subsidiarization)
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our” or “us”) hereby announces that we resolved, at a meeting of our Board of Directors held on March 29, 2024, to enter into a Memorandum of Understanding (the “MOU”) for the purpose of acquiring all of the shares of stock of Japan Gene Medicine Corporation (the “Target Company”) and making it our subsidiary, and commencing the processes and negotiations necessary to enter into the definitive agreement for
Simply Wall St.MEDIROM Healthcare Technologies First Half 2023 Earnings: JP¥72.72 loss per share (vs JP¥37.18 loss in 1H 2022)
MEDIROM Healthcare Technologies ( NASDAQ:MRM ) First Half 2023 Results Key Financial Results Revenue: JP¥3.24b (up 3.0...
Simply Wall St.MEDIROM Healthcare Technologies (NASDAQ:MRM) Might Be Having Difficulty Using Its Capital Effectively
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
© 2024 Yahoo. All rights reserved.